BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9665186)

  • 1. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
    Richards S; Burrett J; Hann I; Chessells J; Hill F; Bailey C
    Leukemia; 1998 Jul; 12(7):1031-6. PubMed ID: 9665186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
    Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
    Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey C; Richards SM
    Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
    Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
    Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
    Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey CC; Richards S
    Leukemia; 1992; 6 Suppl 2():157-61. PubMed ID: 1578921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
    Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
    Durrant IJ; Richards SM
    Br J Haematol; 1993 Sep; 85(1):84-92. PubMed ID: 8251413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001.
    Mitchell C; Richards S; Harrison CJ; Eden T
    Leukemia; 2010 Feb; 24(2):406-18. PubMed ID: 20010621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: preliminary results.
    Shing MM; Li CK; Chik KW; Lam TK; Lai HD; Ng MH; Cheung AY; Yuen PM
    Med Pediatr Oncol; 1999 Feb; 32(2):117-23. PubMed ID: 9950200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
    Hill FG; Richards S; Gibson B; Hann I; Lilleyman J; Kinsey S; Mitchell C; Harrison CJ; Eden OB;
    Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
    Durrant IJ; Prentice HG; Richards SM
    Br J Haematol; 1997 Oct; 99(1):84-92. PubMed ID: 9359507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
    Wheeler K; Chessells JM; Bailey CC; Richards SM
    Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
    Chessells JM; Harrison G; Lilleyman JS; Bailey CC; Richards SM
    Br J Haematol; 1997 Sep; 98(4):945-51. PubMed ID: 9326194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK; Gray RG; Swirsky D; Hayhoe FG
    Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
    Janka-Schaub GE; Goebel U; Graubner U; Haas RJ; Juergens H; Spaar HJ; Winkler K
    Haematol Blood Transfus; 1990; 33():489-93. PubMed ID: 2182442
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
    Eden OB; Harrison G; Richards S; Lilleyman JS; Bailey CC; Chessells JM; Hann IM; Hill FG; Gibson BE
    Leukemia; 2000 Dec; 14(12):2307-20. PubMed ID: 11187922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).
    Pinkerton CR; Bowman A; Holtzel H; Chessells JM
    Arch Dis Child; 1987 Jan; 62(1):12-8. PubMed ID: 3468886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.